Answer
Aprocitentan is a dual endothelin receptor antagonist that inhibits endothelin-1 binding to both ETA and ETB receptors, thereby blocking the effects mediated by these receptors.
Sources for this answer
- JERAYGO 12.5 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked